322 related articles for article (PubMed ID: 14680462)
1. Drug-induced nail abnormalities.
Piraccini BM; Iorizzo M; Antonucci A; Tosti A
Expert Opin Drug Saf; 2004 Jan; 3(1):57-65. PubMed ID: 14680462
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced nail abnormalities.
Piraccini BM; Iorizzo M; Tosti A
Am J Clin Dermatol; 2003; 4(1):31-7. PubMed ID: 12477371
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced nail disorders: incidence, management and prognosis.
Piraccini BM; Tosti A
Drug Saf; 1999 Sep; 21(3):187-201. PubMed ID: 10487397
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced nail diseases.
Piraccini BM; Iorizzo M; Starace M; Tosti A
Dermatol Clin; 2006 Jul; 24(3):387-91. PubMed ID: 16798438
[TBL] [Abstract][Full Text] [Related]
5. Miscellaneous nail presentations.
Bodman MA
Clin Podiatr Med Surg; 1995 Apr; 12(2):327-46. PubMed ID: 7600507
[TBL] [Abstract][Full Text] [Related]
6. Nail abnormalities associated with systemic pathologies.
Zaiac MN; Walker A
Clin Dermatol; 2013; 31(5):627-49. PubMed ID: 24079592
[TBL] [Abstract][Full Text] [Related]
7. Nail toxicities induced by systemic anticancer treatments.
Robert C; Sibaud V; Mateus C; Verschoore M; Charles C; Lanoy E; Baran R
Lancet Oncol; 2015 Apr; 16(4):e181-9. PubMed ID: 25846098
[TBL] [Abstract][Full Text] [Related]
8. Drug reactions affecting the nail unit: diagnosis and management.
Piraccini BM; Iorizzo M
Dermatol Clin; 2007 Apr; 25(2):215-21, vii. PubMed ID: 17430758
[TBL] [Abstract][Full Text] [Related]
9. Melanonychia induced by topical 5-fluorouracil.
Baran R; Laugier P
Br J Dermatol; 1985 May; 112(5):621-5. PubMed ID: 4005160
[TBL] [Abstract][Full Text] [Related]
10. Nail dystrophies.
Bodman MA
Clin Podiatr Med Surg; 2004 Oct; 21(4):663-87, viii. PubMed ID: 15450905
[TBL] [Abstract][Full Text] [Related]
11. Yellow nail syndrome in rheumatoid arthritis: a drug-induced disease?
David-Vaudey E; Jamard B; Hermant C; Cantagrel A
Clin Rheumatol; 2004 Aug; 23(4):376-8. PubMed ID: 15293107
[No Abstract] [Full Text] [Related]
12. Melanoleuconychia: A rare reversible entity.
Sidhu AS; Das L; Singh AS
Postgrad Med J; 2020 Mar; 96(1133):167. PubMed ID: 31597787
[No Abstract] [Full Text] [Related]
13. Transverse nail ridgings (Beau's lines) induced by chemotherapy.
Ben-Dayan D; Mittelman M; Floru S; Djaldetti M
Acta Haematol; 1994; 91(2):89-90. PubMed ID: 7517608
[TBL] [Abstract][Full Text] [Related]
14. Nail changes secondary to environmental influences.
Positano RG; DeLauro TM; Berkowitz BJ
Clin Podiatr Med Surg; 1989 Apr; 6(2):417-29. PubMed ID: 2650851
[TBL] [Abstract][Full Text] [Related]
15. Nail disorders as signs of pediatric systemic disease.
Shah KN; Rubin AI
Curr Probl Pediatr Adolesc Health Care; 2012 Sep; 42(8):204-11. PubMed ID: 22884027
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide-induced melanonychia in a patient with steroid dependent nephrotic syndrome: A rare presentation.
Mehta S; Makkar V; Soha PM; Sethi S; Kaur S
Saudi J Kidney Dis Transpl; 2019; 30(4):978-981. PubMed ID: 31464259
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal melanonychia induced by capecitabine.
Paravar T; Hymes SR
Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
[TBL] [Abstract][Full Text] [Related]
18. Nail biology, morphologic changes, and clinical ramifications: part I.
Sehgal VN; Aggarwal AK; Srivastava G; Chatterjee K
Skinmed; 2011; 9(1):39-46. PubMed ID: 21409961
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced transverse melanonychia.
Ng CF; Tan HJ; Remli R
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34404676
[No Abstract] [Full Text] [Related]
20. Optimal diagnosis and management of common nail disorders.
Lee DK; Lipner SR
Ann Med; 2022 Dec; 54(1):694-712. PubMed ID: 35238267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
